Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Arlo Technologies | ARLO | Apr 17, 2025 | 9.21 | +0.55 |
Arm Holdings ADR | ARM | Apr 17, 2025 | 100.73 | -0.27 |
Armada Hoffler Properties | AHH | Apr 17, 2025 | 6.82 | +3.96 |
Armada Hoffler Properties Pref A | AHH-A | Apr 17, 2025 | 21.36 | +0.30 |
Armata Pharmaceuticals | ARMP | Apr 17, 2025 | 1.23 | +4.24 |
Armlogi Holding | BTOC | Apr 17, 2025 | 1.04 | -7.96 |
Armour Residential Reit | ARR | Apr 17, 2025 | 14.30 | +2.36 |
ARMOUR Residential REIT Pref C | ARR-C | Apr 17, 2025 | 19.94 | +0.55 |
Armstrong World Industries | AWI | Apr 17, 2025 | 134.04 | +0.27 |
Arq | ARQ | Apr 17, 2025 | 3.74 | +3.03 |
Arqit Quantum | ARQQ | Apr 17, 2025 | 14.95 | +3.68 |
Array Technologies | ARRY | Apr 17, 2025 | 4.33 | +6.13 |
ArriVent BioPharma | AVBP | Apr 17, 2025 | 18.14 | +1.34 |
Arrow DJ Global Yield ETF | GYLD | Apr 17, 2025 | 12.30 | -0.12 |
Arrow Electronics | ARW | Apr 17, 2025 | 102.19 | +1.69 |
Arrow Financial | AROW | Apr 17, 2025 | 23.75 | -2.42 |
Arrowhead Pharmaceuticals | ARWR | Apr 17, 2025 | 11.24 | -0.97 |
Arrowmark Financial | BANX | Apr 17, 2025 | 20.24 | +1.66 |
ARS Pharmaceuticals | SPRY | Apr 17, 2025 | 14.88 | 0.00 |
Artelo Biosciences | ARTL | Apr 17, 2025 | 0.95 | -1.67 |
Arteris | AIP | Apr 17, 2025 | 5.82 | -2.02 |
Artesian Resources A | ARTNA | Apr 17, 2025 | 34.66 | +1.20 |
Arthur J. Gallagher & Co | AJG | Apr 17, 2025 | 329.22 | -1.03 |
Artisan Partners Asset Management A | APAM | Apr 17, 2025 | 35.04 | +0.43 |
Artius II Acquisition | AACB | Apr 17, 2025 | 9.90 | 0.00 |
Artius II Acquisition Inc. - Units | AACBU | Apr 17, 2025 | 10.08 | 0.00 |
Artiva Biotherapeutics | ARTV | Apr 17, 2025 | 2.24 | -2.61 |
Artivion | AORT | Apr 17, 2025 | 22.93 | -0.65 |
Arts-Way Manufacturing Co. | ARTW | Apr 17, 2025 | 1.58 | -1.50 |
Arvinas | ARVN | Apr 17, 2025 | 8.60 | +12.42 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.